PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for August 29, 2006 Subscribe to this News Feed    
 

Living a Better Post-Stroke Life

In recent clinical trials the NeuroMove helped 90% of the stroke patients regain significant muscle movement.

Littleton, CO (PRWEB) August 29, 2006 -- A breakthrough at-home device, the NeuroMove™, which is based on monitoring a patients mental attempts to move their muscles, may offer millions of stroke patients new hope of regaining significant muscle movement, and with it increased mobility and independence.

Those fortunate enough to survive a stroke, the third leading cause of death after heart attacks and cancer, affecting some 700,000 Americans each year, may still have to deal with the devastating aftermath. While strokes cost the US economy a staggering $56 billion dollars a year, no price tag can accurately portray the psychological cost to the stroke patient, or to his or her loved ones and caregivers, when the patient is left wholly or partially paralyzed, and possibly also unable to communicate.

Until recently, the medical community believed it was not possible for the post-stroke brain to be, in essence, “rewired” to re-connect the immobile muscles. In fact, physical therapists typically instructed patients who had lost control of their left hand to use their right, or vice versa, as a form of compensation.

Now, however, the seemingly impossible may be possible, thanks to the NeuroMove and its developer, Zynex Medical, an innovative, growing company, based in Littleton, Colorado, that provides electrotherapy products and pain management systems for medical patients with functional disabilities.

In recent clinical trials the NeuroMove helped 90% of the stroke patients regain significant muscle movement. It is FDA-cleared for use with a doctor’s prescription. Thomas Sandgaard, President and CEO of Zynex Medical, explains that the NeuroMove works by “stimulating and reactivating the muscles themselves, while reestablishing brain-muscle connections that can help restore the patient to a greater degree of voluntary movement.”

Clinical studies which have appeared in the journal Archives Physical Medical Rehabilitation (available on www.neuromove.com/clinicalstudies.html) described the technology as being close to three times as effective as physical therapy. The NeuroMove machine uses electrodes, affixed to a problem area, to deliver safe electrical stimulation. At the same time, it monitors and analyzes neural activity, and distinguishes signals that indicate attempts by the brain to move the muscle. When a strong enough attempt is made, the NeuroMove initiates muscle movement. Over time, the patient’s neural connections may be re-learned and re-established, and the affected muscles may once again be able to move on their own.

For more information on the NeuroMove, patient success stories, and a broad overview of stroke rehabilitation, visit www.neuromove.com.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/VGhpci1FbXB0LUVtcHQtTG92ZS1JbnNlLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
Email this story to a colleague
CONTACT INFORMATION
Dian Griesel
THE INVESTOR RELATIONS GROUP
212-825-3210
Email us Here
ATTACHED FILES

The Neuromove
A breakthrough at-home device, the NeuroMove™, which is based on monitoring a patients mental attempts to move their muscles, may offer millions of stroke patients new hope of regaining significant muscle movement, and with it increased mobility and independence.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.